| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |